CHEMICAL SCREENING AND OPTIMIZATION FACILITY - PROTEIN EXPRESSION AND/OR X-RAY CRYSTALLOGRAPHY
化学筛选和优化设施 - 蛋白质表达和/或 X 射线晶体学
基本信息
- 批准号:10942884
- 负责人:
- 金额:$ 26.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-29 至 2026-09-27
- 项目状态:未结题
- 来源:
- 关键词:AdenomyosisBacterial InfectionsChemicalsContraceptive AgentsContraceptive methodsContractsCrystallizationDataDevelopmentDown SyndromeDysmenorrheaFetal Growth RetardationFibroid TumorGenerationsGestational DiabetesGynecologicHealthInfertilityInflammationLactationMuscular DystrophiesNational Institute of Child Health and Human DevelopmentNecrotizing EnterocolitisPelvic PainPeptidesPerformancePerinatalPituitary-dependent Cushing&aposs diseasePlacentaPolycystic Ovary SyndromePre-EclampsiaPremature BirthProductionProteinsRecombinant ProteinsReproductive HealthResearchResolutionRett SyndromeRoleSamplingSepsisStructureUnited States National Institutes of HealthVirus DiseasesVulvodyniaWorkX-Ray Crystallographyautism spectrum disorderendometriosisimprovedinhibitorinterestmastitismicrobiomeprotein expressionprotein purificationscreeningsmall molecule
项目摘要
The Chemical Screening and Optimization Facility (CSOF) fulfills a unique role by identifying, optimizing and conducting production identified small molecules for contraceptive and reproductive health related (e.g., infertility, polycystic ovarian syndrome, fibroids, endometriosis, dysmenorrhea, adenomyosis, gynecologic and/or pelvic pain, and vulvodynia, premature birth, placenta health, improving lactation quality and quantity, preeclampsia, perinatal microbiome, gestational diabetes, inflammation, bacterial infections, viral infections, necrotizing enterocolitis, bronchopulmonary dyplasia, pre-term birth, fetal growth restriction, mastitis, Cushing's disease, Down Syndrome, Ricketts, Muscular Dystrophy, Rett syndrome, sepsis, or Autism) research. One approach is to perform x-ray crystallography studies with active target proteins or peptides in the presence or absence of chemical entities of interest. The research contained within this task order will encompass generation and purification of proteins or peptides of interest, development of crystals, and structural analysis by x-ray crystallography.
化学筛选和优化设施(CSOF)通过鉴定、优化和进行生产鉴定的用于避孕和生殖健康相关的小分子(例如,不孕症、多囊卵巢综合征、纤维瘤、子宫内膜异位症、痛经、子宫腺肌病、妇科和/或盆腔疼痛和外阴痛、早产、胎盘健康、改善泌乳质量和数量、先兆子痫、围产期微生物组、妊娠糖尿病、炎症、细菌感染、病毒感染、坏死性小肠结肠炎、支气管肺发育不良、早产、胎儿生长受限、乳腺炎、库欣病,唐氏综合征、里基茨综合征、肌营养不良、雷特综合征、败血症或自闭症)研究。一种方法是在存在或不存在感兴趣的化学实体的情况下用活性靶蛋白或肽进行X射线晶体学研究。该任务订单中包含的研究将包括感兴趣的蛋白质或肽的生成和纯化,晶体的开发以及X射线晶体学的结构分析。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LEYI GONG其他文献
LEYI GONG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LEYI GONG', 18)}}的其他基金
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - MANAGEMENT, ADMINISTRATION AND DATABASE CORE FUNCTION ACTIVITIES
化学筛选和优化设施 - 管理、行政和数据库核心功能活动
- 批准号:
10942871 - 财政年份:2023
- 资助金额:
$ 26.12万 - 项目类别:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - SCALABLE QUANTITIES
化学筛选和优化设施 - 可扩展数量
- 批准号:
10942882 - 财政年份:2023
- 资助金额:
$ 26.12万 - 项目类别:
Task B28: Efficacy Studies for Therapeutics Development
任务 B28:治疗药物开发的功效研究
- 批准号:
10703289 - 财政年份:2022
- 资助金额:
$ 26.12万 - 项目类别:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY (CSOF) – DRUG AND SUBSTANCE
化学筛选和优化设施 (CSOF) – 药物和物质
- 批准号:
10710754 - 财政年份:2022
- 资助金额:
$ 26.12万 - 项目类别:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY (CSOF) - CHEMICAL OPTIMIZATION APPROACHES
化学筛选和优化设施 (CSOF) - 化学优化方法
- 批准号:
10710755 - 财政年份:2022
- 资助金额:
$ 26.12万 - 项目类别:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY- HIGH THROUGHPUT SCREENING
化学筛选和优化设施 - 高通量筛选
- 批准号:
10421851 - 财政年份:2021
- 资助金额:
$ 26.12万 - 项目类别:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - "STRUCTURE ACTIVITY RELATIONSHIPS"
化学筛选和优化设施 - “结构活性关系”
- 批准号:
10274476 - 财政年份:2020
- 资助金额:
$ 26.12万 - 项目类别:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - "SCALABLE QUANTITIES OFACTIVE PHARMACEUTICAL INGREDIENTS"
化学筛选和优化设施 - “活性药物成分的可扩展数量”
- 批准号:
10274475 - 财政年份:2020
- 资助金额:
$ 26.12万 - 项目类别:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - PROTEIN GENERATION
化学筛选和优化设施 - 蛋白质生成
- 批准号:
10022550 - 财政年份:2019
- 资助金额:
$ 26.12万 - 项目类别:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - STRUCTURE ACTIVITY RELATIONSHIPS
化学筛选和优化设施 - 结构活性关系
- 批准号:
10022551 - 财政年份:2019
- 资助金额:
$ 26.12万 - 项目类别:
相似海外基金
Derivation and validation of a clinical prediction rule to identify febrile infants 61 to 90 days old at low and non-negligible risk of invasive bacterial infections
推导和验证临床预测规则,以识别 61 至 90 天大的发热婴儿,其侵袭性细菌感染的风险较低且不可忽略
- 批准号:
10574286 - 财政年份:2023
- 资助金额:
$ 26.12万 - 项目类别:
New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections
IFN诱导的OAS蛋白在针对细菌感染的先天免疫防御中的新作用
- 批准号:
10649771 - 财政年份:2023
- 资助金额:
$ 26.12万 - 项目类别:
Structural and functional studies of YbtPQ for fighting bacterial infections
YbtPQ 对抗细菌感染的结构和功能研究
- 批准号:
10644889 - 财政年份:2023
- 资助金额:
$ 26.12万 - 项目类别:
A gut feeling: How can gastrointestinal bacterial infections alter female reproductive tract immunity and control of sexually transmitted infections
直觉:胃肠道细菌感染如何改变女性生殖道免疫力和性传播感染的控制
- 批准号:
MR/X031993/1 - 财政年份:2023
- 资助金额:
$ 26.12万 - 项目类别:
Research Grant
Molecular probes to diagnose pathoadapatations in bacterial infections
诊断细菌感染病理适应的分子探针
- 批准号:
EP/X014479/1 - 财政年份:2023
- 资助金额:
$ 26.12万 - 项目类别:
Research Grant
Using Small Area Variation Analysis to Investigate Sources of Practice Variation for Febrile Infants at Risk for Invasive Bacterial Infections
使用小面积变异分析来调查有侵袭性细菌感染风险的发热婴儿的实践变异来源
- 批准号:
10588846 - 财政年份:2023
- 资助金额:
$ 26.12万 - 项目类别:
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
宿主定向 Orynotide 用于治疗耐多药革兰氏阴性细菌感染
- 批准号:
10674221 - 财政年份:2023
- 资助金额:
$ 26.12万 - 项目类别:
SimCell vaccines against Staphylococcus aureus bacterial infections
针对金黄色葡萄球菌细菌感染的 SimCell 疫苗
- 批准号:
10073241 - 财政年份:2023
- 资助金额:
$ 26.12万 - 项目类别:
Grant for R&D
I-Corps: Mitigating Multidrug Resistant Bacterial Infections with Biocompatible and Environmentally Benign Nanoantibiotics
I-Corps:利用生物相容性且对环境无害的纳米抗生素减轻多重耐药细菌感染
- 批准号:
2306943 - 财政年份:2023
- 资助金额:
$ 26.12万 - 项目类别:
Standard Grant
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
- 批准号:
10549640 - 财政年份:2023
- 资助金额:
$ 26.12万 - 项目类别: